# Lexicon Pharmaceuticals, Inc.: filings

LXRX · Nasdaq · CIK 1062822 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lxrx.md) · [Financials](/companies/lxrx/financials.md) · [Filings](/companies/lxrx/filings.md) · [Insiders](/companies/lxrx/insiders.md)

## Reports and events: 314 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 512, 8-K 193, 10-Q 53, 3 28, SC 13G/A 27, CORRESP 22, SC 13D/A 22, DEFA14A 20, DEF 14A 19, 10-K 18, UPLOAD 17, 424B5 15, CT ORDER 12, EFFECT 11, S-3 11, ARS 10, PRE 14A 10, S-8 10, FWP 9, D 8, SC 13G 5, 424B2 4, 5 4, 8-K/A 4, S-3/A 4, POS AM 3, SCHEDULE 13G/A 3, 10-Q/A 2, 144 2, S-3ASR 2, S-3MEF 2, SCHEDULE 13D/A 2, 10-K/A 1, 4/A 1, RW 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:05 ET | [10-Q](/filings/0001062822-26-000117.md) | Quarterly report, period 2026-06-30 | 0001062822-26-000117 |
| 2026-08-06 | 07:33 ET | [8-K](/filings/0001062822-26-000112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-26-000112 |
| 2026-05-08 | 21:42 ET | [SCHEDULE 13D/A](/filings/0001193125-26-215295.md) | Ownership report, active investor, amended | 0001193125-26-215295 |
| 2026-05-07 | 16:21 ET | [10-Q](/filings/0001062822-26-000101.md) | Quarterly report, period 2026-03-31 | 0001062822-26-000101 |
| 2026-05-07 | 07:31 ET | [8-K](/filings/0001062822-26-000098.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-26-000098 |
| 2026-05-06 | 16:01 ET | [8-K](/filings/0001062822-26-000094.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062822-26-000094 |
| 2026-04-30 | 16:05 ET | [8-K](/filings/0001062822-26-000065.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001062822-26-000065 |
| 2026-03-16 | 16:03 ET | [DEF 14A](/filings/0001062822-26-000056.md) | Proxy statement, period 2026-03-16 | 0001062822-26-000056 |
| 2026-03-05 | 16:50 ET | [10-K](/filings/0001062822-26-000050.md) | Annual report, period 2025-12-31 | 0001062822-26-000050 |
| 2026-03-05 | 07:01 ET | [8-K](/filings/0001062822-26-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-26-000047 |
| 2026-02-02 | 21:54 ET | [SCHEDULE 13D/A](/filings/0001193125-26-034176.md) | Ownership report, active investor, amended | 0001193125-26-034176 |
| 2026-02-02 | 16:49 ET | [8-K](/filings/0001193125-26-033793.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-033793 |
| 2026-01-29 | 16:37 ET | [8-K](/filings/0001193125-26-029514.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-029514 |
| 2025-11-10 | 16:31 ET | [8-K](/filings/0001193125-25-274383.md) | 8.01 Other events | 0001193125-25-274383 |
| 2025-11-06 | 16:57 ET | [8-K](/filings/0001193125-25-270020.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-270020 |
| 2025-11-06 | 16:10 ET | [10-Q](/filings/0001062822-25-000054.md) | Quarterly report, period 2025-09-30 | 0001062822-25-000054 |
| 2025-11-06 | 07:33 ET | [8-K](/filings/0001062822-25-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-25-000049 |
| 2025-08-06 | 16:15 ET | [10-Q](/filings/0001628280-25-038340.md) | Quarterly report, period 2025-06-30 | 0001628280-25-038340 |
| 2025-08-06 | 07:31 ET | [8-K](/filings/0001062822-25-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-25-000042 |
| 2025-07-28 | 07:36 ET | [8-K](/filings/0001062822-25-000037.md) | 8.01 Other events | 0001062822-25-000037 |
| 2025-07-03 | 09:10 ET | [8-K](/filings/0001062822-25-000035.md) | 8.01 Other events | 0001062822-25-000035 |
| 2025-06-03 | 16:04 ET | [8-K](/filings/0001062822-25-000033.md) | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001062822-25-000033 |
| 2025-05-14 | 07:08 ET | [10-Q](/filings/0001062822-25-000029.md) | Quarterly report, period 2025-03-31 | 0001062822-25-000029 |
| 2025-05-13 | 16:03 ET | [8-K](/filings/0001062822-25-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-25-000027 |
| 2025-04-22 | 07:07 ET | [DEF 14A](/filings/0001062822-25-000023.md) | Proxy statement, period 2025-04-22 | 0001062822-25-000023 |
| 2025-03-28 | 07:59 ET | [8-K](/filings/0001062822-25-000019.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001062822-25-000019 |
| 2025-03-07 | 16:02 ET | [10-K](/filings/0001062822-25-000013.md) | Annual report, period 2024-12-31 | 0001062822-25-000013 |
| 2025-03-06 | 16:03 ET | [8-K](/filings/0001062822-25-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-25-000008 |
| 2025-01-07 | 16:08 ET | [8-K](/filings/0001062822-25-000005.md) | 3.01 Delisting notice | 0001062822-25-000005 |
| 2025-01-02 | 16:04 ET | [8-K](/filings/0001062822-25-000003.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062822-25-000003 |
| 2024-12-09 | 21:33 ET | [SC 13D/A](/filings/0001193125-24-273713.md) | Ownership report, active investor, amended | 0001193125-24-273713 |
| 2024-11-22 | 16:05 ET | [8-K](/filings/0001062822-24-000064.md) | 2.05 Exit or disposal costs | 0001062822-24-000064 |
| 2024-11-20 | 16:07 ET | [8-K](/filings/0001062822-24-000062.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062822-24-000062 |
| 2024-11-13 | 07:12 ET | [10-Q](/filings/0001062822-24-000060.md) | Quarterly report, period 2024-09-30 | 0001062822-24-000060 |
| 2024-11-12 | 16:06 ET | [8-K](/filings/0001062822-24-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-24-000057 |
| 2024-10-16 | 16:37 ET | [8-K](/filings/0001062822-24-000054.md) | 1.01 Entry into a material agreement | 0001062822-24-000054 |
| 2024-09-16 | 06:51 ET | [8-K](/filings/0001062822-24-000051.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062822-24-000051 |
| 2024-08-02 | 07:06 ET | [10-Q](/filings/0001062822-24-000046.md) | Quarterly report, period 2024-06-30 | 0001062822-24-000046 |
| 2024-08-01 | 16:05 ET | [8-K](/filings/0001062822-24-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-24-000043 |
| 2024-07-29 | 17:44 ET | [SC 13D/A](/filings/0001193125-24-187770.md) | Ownership report, active investor, amended | 0001193125-24-187770 |
| 2024-07-08 | 09:15 ET | [8-K](/filings/0001062822-24-000036.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062822-24-000036 |
| 2024-07-01 | 16:05 ET | [8-K](/filings/0001062822-24-000032.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001062822-24-000032 |
| 2024-05-14 | 17:05 ET | [SC 13D/A](/filings/0001193125-24-138357.md) | Ownership report, active investor, amended | 0001193125-24-138357 |
| 2024-05-10 | 16:15 ET | [8-K](/filings/0001062822-24-000029.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001062822-24-000029 |
| 2024-05-02 | 16:08 ET | [10-Q](/filings/0001062822-24-000024.md) | Quarterly report, period 2024-03-31 | 0001062822-24-000024 |
| 2024-05-02 | 16:07 ET | [8-K](/filings/0001062822-24-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-24-000023 |
| 2024-04-29 | 09:00 ET | [8-K](/filings/0001062822-24-000020.md) | 5.02 Departure or appointment of officers or directors | 0001062822-24-000020 |
| 2024-03-26 | 07:05 ET | [DEF 14A](/filings/0001062822-24-000014.md) | Proxy statement, period 2024-03-25 | 0001062822-24-000014 |
| 2024-03-25 | 16:00 ET | [10-K](/filings/0001062822-24-000008.md) | Annual report, period 2023-12-31 | 0001062822-24-000008 |
| 2024-03-13 | 21:20 ET | [SC 13D/A](/filings/0001193125-24-067142.md) | Ownership report, active investor, amended | 0001193125-24-067142 |

Page 1 of 7. [Older](/companies/lxrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.